Cassava Sciences | PTIE - Beneficio Operativo

Precio De Mercado
1.67
Cambio Diario
-0.10 -5.65%
Mensual
-28.02%
Anual
1.21%
Q1 Expectativa
1.62




Beneficio Operativo Cambio Fecha
Abbott USD 2.25B 73M 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Cara Therapeutics USD -2.39M 3.49M 2025-03
Cassava Sciences USD -13.55M 1.69M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Geron USD -10.79M 3.1M 2025-12
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.06B 437M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12